INmune Bio Inc (INMB) — Financial Flexibility Index
INmune Bio Inc (INMB) has a Financial Flexibility Index of -0.66x as of September 2025. Free cash flow of $-5.25 Million (operating CF $-5.44 Million minus capex $193.00K) represents -1% of total liabilities ($7.98 Million). Check INmune Bio Inc (INMB) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INmune Bio Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for INmune Bio Inc across 10 annual periods. See INmune Bio Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for INmune Bio Inc (2015–2024)
Year-by-year free cash flow to debt coverage for INmune Bio Inc. For the full company profile including market capitalisation, see INmune Bio Inc (INMB) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.47x | $-33.36 Million | $-33.36 Million | $7.46 Million | ▼ -603.6% |
| 2023 | -0.64x | $-11.98 Million | $-11.98 Million | $18.86 Million | ▲ +39.3% |
| 2022 | -1.05x | $-22.69 Million | $-22.69 Million | $21.69 Million | ▼ -52.7% |
| 2021 | -0.68x | $-13.50 Million | $-28.50 Million | $19.72 Million | ▲ +85.4% |
| 2020 | -4.70x | $-8.94 Million | $-8.94 Million | $1.90 Million | ▲ +24.9% |
| 2019 | -6.26x | $-5.38 Million | $-5.38 Million | $860.54K | ▼ -150.3% |
| 2018 | -2.50x | $-2.06 Million | $-2.06 Million | $823.77K | ▼ -17.0% |
| 2017 | -2.14x | $-661.83K | $-761.83K | $309.72K | ▼ -304.5% |
| 2016 | -0.53x | $-317.38K | $-317.38K | $600.81K | ▲ +10.3% |
| 2015 | -0.59x | $-18.12K | $-18.12K | $30.75K | — |